v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at the beginning at Dec. 31, 2024 $ (21,380)   $ 263,879 $ (285,259)
Balance at the beginning (in shares) at Dec. 31, 2024   3,262,000    
Issuance of common stock in the 2025 PIPE   5,213,000    
Issuance of common stock in a private placement 53,190 $ 1 53,189  
Vesting of restricted stock units   20,000    
Stock-based compensation expense 834   834  
Net loss (26,970)     (26,970)
Balance at the end at Mar. 31, 2025 5,674 $ 1 317,902 (312,229)
Balance at the end (in shares) at Mar. 31, 2025   8,495,000    
Balance at the beginning at Dec. 31, 2025 (187,762) $ 1 339,522 (527,285)
Balance at the beginning (in shares) at Dec. 31, 2025   9,775,000    
Issuance of common stock in the 2025 PIPE   1,400,000    
Issuance of common stock in a private placement 26,858   26,858  
Issuance of common stock upon warrant exercise, (in share)   289,000    
Issuance of common stock upon warrant exercise 8,065   8,065  
Vesting of restricted stock units   18,000    
Issuance of common stock upon option exercises $ 92   92  
Issuance of common stock upon option exercises, shares 8 8,000    
Stock-based compensation expense $ 2,105   2,105  
Net loss (127,505)     (127,505)
Balance at the end at Mar. 31, 2026 $ (278,147) $ 1 $ 376,642 $ (654,790)
Balance at the end (in shares) at Mar. 31, 2026   11,490,000